PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer


Basic Trial Information

Protocol Phase:Phase III
Study Category:Treatment
Current Protocol StatusActive
Age18 to 65
Protocol SponsorPharmaceutical/Industry
Primary ID020221
Other IDNCT00045968
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: